Condensed Consolidated and Combined Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Net sales				$ 300
Cost of goods sold
Gross profit				300
Operating Expenses
Research and development	400,658	681,646	1,129,772	1,442,131
Selling, general and administrative	2,532,651	351,330	5,562,873	1,332,962
Total operating expenses	2,933,309	1,032,976	6,692,645	2,775,093
Operating loss	(2,933,309)	(1,032,976)	(6,692,645)	(2,774,793)
Other Income (Expense)
Change in fair value of derivative liabilities	24,966,700		16,784,200
Issuance of common stock and warrants			(17,820,998)
Interest income	171		482
Interest expense	(19,184)		(22,923)
Other income (expense)	4,038	391	4,037	666
Total other income (expense)	24,951,725	391	(1,055,202)	666
Net Income (loss)	$ 22,018,416	$ (1,032,585)	$ (7,747,847)	$ (2,774,127)
Weighted average number of shares of common stock outstanding, basic (in Shares)	86,913,581	69,800,000	82,556,000	69,800,000
Basic net income (loss) per share of common stock (in Dollars per share)	$ 0.25	$ (0.01)	$ (0.09)	$ (0.04)
Weighted average number of shares of common stock outstanding, diluted (in Shares)	96,159,497	69,800,000	82,556,000	69,800,000
Diluted net income (loss) per share of common stock (in Dollars per share)	$ 0.23	$ (0.01)	$ (0.09)	$ (0.04)